Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Pfizer, Inc.
  6. Company
    PFE   US7170811035

PFIZER, INC.

(PFE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Pfizer, Inc.
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines and vaccines. IH therapeutic areas include internal medicine, vaccines, oncology, inflammation and immunology, rare diseases and consumer healthcare. EH includes legacy brands, branded generics, generic sterile injectable products, biosimilars and infusion systems. EH also includes a research and development (R&D) organization, as well as its contract manufacturing business. Its brands include Prevnar 13, Xeljanz, Eliquis, Lipitor, Celebrex, Pristiq and Viagra.

Number of employees : 78 500 people.
Sales per Business
2020
USD (in Million)%
Oncology10,86725.9%
Internal Medicine9,00321.5%
Hospital7,96119%
Vaccines6,57515.7%
Inflammation & Immunology4,56710.9%
Rare Disease2,9367%
Sales per region
20192020Delta
USD (in Million)%USD (in Million)%
United States23,85246.1%21,71251.8% -8.97%
Developed Europe8,70116.8%7,78818.6% -10.49%
Emerging Markets8,07615.6%5,85814% -27.47%
Japan4,1408%2,5146% -39.26%
China4,6589%2,5146% -46.01%
Developed Rest of World2,3254.5%1,5223.6% -34.56%
Managers
NameAgeSinceTitle
Albert Bourla582020Chairman, Chief Executive & Operating Officer
Frank D'Amelio622007Chief Financial Officer & EVP-Global Supply
Mikael Dolsten612019Chief Scientific Officer & Research President
Lidia Fonseca51-Executive VP, Chief Digital & Technology Officer
Aida Habtezion--Chief Medical Officer
Rady Johnson592013Executive VP, Chief Compliance & Risk Officer
Suzanne Nora Johnson632007Independent Director
Helen H. Hobbs, Dr.672011Independent Director
Shantanu Narayen56-Lead Independent Director
James Smith602014Independent Director
Members of the board
NameAgeSinceTitle
Albert Bourla582020Chairman, Chief Executive & Operating Officer
Suzanne Nora Johnson632007Independent Director
Helen H. Hobbs, Dr.672011Independent Director
Shantanu Narayen56-Lead Independent Director
James Smith602014Independent Director
Joseph Echevarria632015Independent Director
Ronald E. Blaylock602017Independent Director
Dan R. Littman, Dr.672018Independent Director
Scott Gottlieb, Dr.472019Independent Director
James R. Quincey552020Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 9,448,693,867 5,595,584,817 59.2% 3,851,000,000 40.8% 59.2%
Shareholders
NameEquities%
The Vanguard Group, Inc. 426,692,364 7.62%
SSgA Funds Management, Inc. 274,886,855 4.91%
Wellington Management Co. LLP 249,780,583 4.46%
Capital Research & Management Co. (World Investors) 230,086,394 4.11%
Capital Research & Management Co. 142,320,700 2.54%
BlackRock Fund Advisors 129,420,103 2.31%
Geode Capital Management LLC 94,148,117 1.68%
Northern Trust Investments, Inc.(Investment Management) 65,053,051 1.16%
Norges Bank Investment Management 60,296,992 1.08%
State Farm Investment Management Corp. 56,536,168 1.01%
Holdings
NameEquities%Valuation
Pfizer Limited (500680) 29,243,04263.9%2,067,337,731 USD
SpringWorks Therapeutics, Inc. (SWTX) 4,583,0479.34%373,701,652 USD
BioAtla, Inc. (BCAB) 2,238,0906.96%96,349,775 USD
Cortexyme, Inc. (CRTX) 2,056,3776.95%85,072,316 USD
Morphic Holding, Inc. (MORF) 1,265,6353.49%62,471,744 USD
4D Molecular Therapeutics, Inc. (FDMT) 1,666,6586.23%44,266,436 USD
Sosei Group Corporation (4565) 1,885,1362.33%26,934,201 USD
NextCure, Inc. (NXTC) 1,970,7597.14%15,470,458 USD
RaQualia Pharma Inc. (4579) 743,0003.55%7,151,873 USD
Mersana Therapeutics, Inc. (MRSN) 00.0000%
Markets and indexes
-
- International Market
- DJIA / S&P 100, S&P 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Stock Exchange Codes
- Bloomberg Code :  PFIZ11B:BZ
- Reuters Code :  
- Datastream Code :  
Company contact information
Pfizer, Inc.
235 Street East 42nd
NY 10017 New York City, New York


Phone : +1 212 573 2323
Fax : +1 212 573 7851
web site : http://www.pfizer.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Pfizer, Inc.
Sector Other Pharmaceuticals
1st jan.Capitalization (M$)
PFIZER, INC.7.61%221 725
JOHNSON & JOHNSON3.96%430 876
ROCHE HOLDING AG11.75%324 905
NOVARTIS AG2.56%209 282
ABBVIE INC.7.05%202 586
ELI LILLY AND COMPANY31.88%201 295
MERCK & CO., INC.-6.86%192 918
NOVO NORDISK A/S20.31%188 623
ASTRAZENECA PLC14.01%152 574
BRISTOL-MYERS SQUIBB COMPANY6.30%147 234
AMGEN INC.4.35%137 841
SANOFI11.47%130 644
GLAXOSMITHKLINE PLC3.93%97 146
JIANGSU HENGRUI MEDICINE CO., LTD.-23.09%69 276
CHUGAI PHARMACEUTICAL CO., LTD.-22.77%64 846
ALLERGAN PLC0.97%63 659
BAYER AG6.53%60 005
TAKEDA PHARMACEUTICAL COMPANY LIMITED-0.85%53 004
DAIICHI SANKYO COMPANY, LIMITED-28.98%43 776
ASTELLAS PHARMA INC.21.89%33 381
EISAI CO., LTD.63.80%32 894